[ITCI] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
09-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 13.39%
YoY- -58.29%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 125,810 71,870 21,606 7,369 0 0 31 299.13%
PBT -24,215 -53,507 -76,931 -55,184 -34,862 -41,523 -22,874 0.95%
Tax 43 1 -23 -1,506 -1,514 -1,868 -4 -
NP -24,258 -53,508 -76,908 -55,184 -34,862 -41,523 -22,870 0.98%
Tax Rate - - - - - - - -
Total Cost 150,068 125,378 98,514 62,552 34,862 41,523 22,901 36.77%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -19.28 -74.45 -355.95 -748.90 0.00 0.00 -74,365.66 -74.73%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.25 -0.57 -0.95 -0.79 -0.63 -0.76 -0.53 -11.76%
EPS Diluted -0.25 -0.57 -0.95 -0.79 -0.63 -0.76 -0.53 -11.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.